These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14623771)

  • 61. Generation of a NK1R-CreER knockin mouse strain to study cells involved in Neurokinin 1 Receptor signaling.
    Huang H; Kuzirian MS; Cai X; Snyder LM; Cohen J; Kaplan DH; Ross SE
    Genesis; 2016 Nov; 54(11):593-601. PubMed ID: 27712014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Substance P enhances the local activation of NK
    Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
    BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of neurokinin-1 receptors on cultured dorsal root ganglion neurons from the adult rat.
    Segond von Banchet G; Petersen M; Schaible HG
    Neuroscience; 1999 May; 90(2):677-84. PubMed ID: 10215169
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells.
    Garland AM; Grady EF; Payan DG; Vigna SR; Bunnett NW
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):177-86. PubMed ID: 7524481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Involvement of neurokinin 1 receptor within the cerebrospinal fluid‑contacting nucleus in visceral pain.
    Zhang C; Li Y; Wang X; Fei Y; Zhang L
    Mol Med Rep; 2017 Jun; 15(6):4300-4304. PubMed ID: 28440440
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Persistence of immunoreactive neurokinins in the dorsal horn of barbiturate anaesthetized and spinal cats, following release by tibial nerve stimulation.
    Hope PJ; Lang CW; Duggan AW
    Neurosci Lett; 1990 Oct; 118(1):25-8. PubMed ID: 2175408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blockade of neurokinin-1 receptors in the ventral respiratory column does not affect breathing but alters neurochemical release.
    Muere C; Neumueller S; Olesiak S; Miller J; Hodges MR; Pan L; Forster HV
    J Appl Physiol (1985); 2015 Mar; 118(6):732-41. PubMed ID: 25635003
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.
    Arapulisamy O; Mannangatti P; Jayanthi LD
    J Biol Chem; 2013 Oct; 288(40):28599-610. PubMed ID: 23979140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enzyme immunoassay for tachykinin-like immunoreactivity in the guinea pig spinal cord.
    Renzi D; Maillet S; Grassi J; Mantellini P; Santicioli P; Theodorsson E; Surrenti C; Geppetti P
    J Neurochem; 1991 Jan; 56(1):281-6. PubMed ID: 1702832
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
    Rose C; Camus A; Schwartz JC
    Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tachykinins produce fast and slow depolarizations in sympathetic neurons of rat coeliac-superior mesenteric ganglia.
    Konishi S; Song SY; Ogawa T; Kanazawa I
    Brain Res; 1989 Jun; 490(1):162-5. PubMed ID: 2474359
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme.
    Wang LH; Ahmad S; Benter IF; Chow A; Mizutani S; Ward PE
    Peptides; 1991; 12(6):1357-64. PubMed ID: 1726123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Ohba M; Kisara K; Terenius L
    Regul Pept; 1993 Jul; 46(1-2):326-8. PubMed ID: 7692527
    [No Abstract]   [Full Text] [Related]  

  • 77. The spinal generator of ejaculation: Functional consequences of chronic spinalization and effect of substance P in anesthetized rats.
    Chéhensse C; Clément P; Joussain C; Bernabé J; Giuliano F
    Neuroscience; 2016 Nov; 336():12-19. PubMed ID: 27592274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization and regulation of neurokinin1 receptors in primary cultures of rat neonatal spinal neurons.
    Seybold VS; Abrahams LG
    Neuroscience; 1995 Dec; 69(4):1263-73. PubMed ID: 8848112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological properties of a slow C-fiber response induced by stimulation of greater splanchnic nerve in an isolated spinal cord-nerve preparation of the newborn rat.
    Yanagisawa M; Hosoki R; Otsuka M
    Regul Pept; 1993 Jul; 46(1-2):285-6. PubMed ID: 7692517
    [No Abstract]   [Full Text] [Related]  

  • 80. Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology.
    Stahl SM
    J Clin Psychiatry; 1999 Feb; 60(2):77-8. PubMed ID: 10084632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.